Category: Female Reproductive Health, Ovarian Reserve & IVF Support Nutraceutical | Form: Oral Tablet | Pack Size: 30 Tablets | Manufacturer: Galaxy Nutraceuticals | Status: Dietary Supplement — DRAP Registered
What is Glasterone-D Plus?
Glasterone-D Plus is a specialised female reproductive health nutraceutical by Galaxy Nutraceuticals — combining five targeted nutritional ingredients in a single daily tablet formulated specifically for women dealing with infertility, diminished ovarian reserve, and those preparing for or undergoing IVF (In Vitro Fertilisation) or other assisted reproductive treatment. While general women's health supplements provide broad nutritional support, Glasterone-D Plus is specifically positioned and formulated around the nutritional requirements of the most challenging reproductive scenarios — women with low Anti-Müllerian Hormone (AMH) levels, reduced Antral Follicle Count (AFC), elevated FSH, or poor ovarian response to stimulation. Each ingredient has been selected for its specific documented role in ovarian follicular biology, oocyte quality, hormonal balance, and reproductive endocrinology — from Diosgenin's phytoestrogenic follicular support and FSH modulation, to Selenium and Vitamin E's critical antioxidant protection of developing oocytes, Vitamin D3's direct role in AMH production and ovarian hormone regulation, and Calcium's essential contribution to oocyte activation and cellular signalling. Glasterone-D Plus is designed to nutritionally optimise the ovarian environment during the months preceding fertility treatment — and during active treatment cycles — to support the best possible egg quality, ovarian response, and reproductive outcome under reproductive specialist supervision.
What is Glasterone-D Plus Used For?
- Diminished ovarian reserve — nutritional support for women with low AMH, reduced AFC, or elevated FSH indicating reduced ovarian reserve (انڈوں کی کم تعداد)
- IVF and assisted reproductive treatment preparation — optimising ovarian nutritional status and egg quality in the 3 months preceding IVF stimulation cycles
- Poor ovarian response — nutritional support for women who have previously had a poor response to IVF stimulation with fewer than expected mature eggs retrieved
- Infertility — comprehensive ovarian health nutritional support for women investigating or treating infertility of ovarian or unexplained origin (بانجھ پن)
- Egg quality improvement — antioxidant and nutritional support for oocyte nuclear and cytoplasmic maturation quality during follicular development
- Hormonal balance — phytoestrogenic and Vitamin D3-mediated support for balanced ovarian hormone production and FSH regulation (ہارمون کا توازن)
- Ovulation support — nutritional support for healthy follicular development and regular spontaneous ovulation in women with ovulatory dysfunction
- Post-chemotherapy or post-surgical ovarian support — nutritional support for women with iatrogenic ovarian reserve reduction following chemotherapy or ovarian surgery
- Perimenopause ovarian support — supporting remaining ovarian function and hormonal transition in perimenopausal women
How Does Glasterone-D Plus Work?
Each ingredient in Glasterone-D Plus targets a specific aspect of ovarian biology and reproductive function — together forming a comprehensive nutritional support system for the developing follicle and oocyte:
Diosgenin 20mg — Phytoestrogenic Follicular and Hormonal Support:
Diosgenin is a naturally occurring steroidal saponin extracted from wild yam (Dioscorea species) — with structural similarity to human steroid hormones including oestrogen and progesterone. In the context of ovarian reserve and fertility support, Diosgenin's phytoestrogenic activity is particularly relevant — acting as a selective oestrogen receptor modulator that supports follicular development by modulating oestrogen signalling in ovarian granulosa cells without the potency or risks of pharmaceutical oestrogen. In women with diminished ovarian reserve, declining oestrogen production from the reduced follicular pool creates a feedback loop of rising FSH — Diosgenin's mild oestrogenic activity in the hypothalamic-pituitary-ovarian axis may help modulate this FSH elevation, supporting a more favourable hormonal environment for remaining follicular development. Diosgenin also demonstrates anti-inflammatory properties in ovarian stromal tissue — potentially reducing the chronic low-grade ovarian inflammation that accelerates follicular atresia and contributes to premature ovarian ageing. At 20mg, Glasterone-D Plus provides a carefully calibrated phytoestrogenic dose that supports these ovarian mechanisms while remaining within a safe nutritional supplementation range.
Selenium 200mcg — Antioxidant Protection of the Oocyte:
Selenium is an essential trace mineral and the critical cofactor for glutathione peroxidase (GPx) enzymes — the body's primary defence against oxidative damage to biological macromolecules. Developing oocytes are among the most metabolically active and oxidatively vulnerable cells in the female body — the extensive mitochondrial activity required to power the meiotic divisions of egg maturation generates large quantities of reactive oxygen species (ROS) that must be continuously neutralised to prevent oocyte DNA strand breaks, mitochondrial dysfunction, and spindle assembly errors. These forms of oxidative oocyte damage are the primary cause of poor egg quality, failed fertilisation, and early embryo arrest — and are particularly pronounced in women with diminished ovarian reserve where remaining follicles have been exposed to cumulative oxidative stress over a longer reproductive lifespan. Selenium-dependent GPx enzymes in follicular fluid and oocyte cytoplasm provide the first line of antioxidant defence against this oxidative damage — protecting oocyte DNA integrity, mitochondrial function, and meiotic spindle assembly. At 200mcg — the upper recommended daily selenium intake — Glasterone-D Plus provides maximal selenium-dependent antioxidant support without approaching toxicity. Selenium also supports thyroid hormone activation — relevant because hypothyroidism and thyroid autoimmunity are significantly more prevalent in women with ovarian reserve issues and directly impair reproductive outcomes.
Vitamin D3 25mcg (1000 IU) — AMH, Follicular Development, and Ovarian Reserve:
Vitamin D3 (cholecalciferol) has emerged as one of the most important micronutrients in reproductive endocrinology — the Vitamin D receptor (VDR) is expressed in ovarian granulosa cells, theca cells, the uterus, fallopian tubes, and pituitary gland, confirming direct regulatory roles throughout the reproductive system. Of particular relevance to ovarian reserve, Vitamin D3 directly modulates the expression of Anti-Müllerian Hormone (AMH) by ovarian granulosa cells — AMH being the most sensitive and reliable marker of ovarian reserve. Clinical studies have consistently demonstrated that Vitamin D deficient women have significantly lower AMH levels than Vitamin D sufficient women — and that Vitamin D3 supplementation in deficient women produces measurable improvements in AMH. Vitamin D3 also regulates FSH receptor expression on granulosa cells — improving follicular sensitivity to FSH stimulation — a critically important effect in women undergoing IVF stimulation where poor FSH receptor response contributes to suboptimal egg retrieval numbers. Additionally, Vitamin D3 modulates ovarian steroidogenesis, supports progesterone production by the corpus luteum after ovulation, improves endometrial receptivity for embryo implantation, and reduces the pro-inflammatory cytokine environment that accelerates follicular atresia. Pakistan has among the highest global rates of Vitamin D deficiency — making Vitamin D3 supplementation particularly impactful for reproductive outcomes in Pakistani women.
Vitamin E 180mg — Oocyte Membrane and Follicular Fluid Antioxidant:
Vitamin E (alpha-tocopherol) is the most potent fat-soluble antioxidant in the human body — concentrated at high levels in the lipid bilayer of cell membranes where it intercepts and neutralises lipid peroxyl radicals before they propagate destructive chain reactions of lipid peroxidation through membrane phospholipids. In reproductive biology, Vitamin E is found at particularly high concentrations in follicular fluid — the nutritive microenvironment immediately surrounding the developing oocyte — where it provides critical membrane protection for the oocyte and surrounding granulosa cells during the months-long follicular growth phase. The oocyte's plasma membrane — rich in polyunsaturated fatty acids essential for its fluidity and receptor function — is especially vulnerable to lipid peroxidation, and oxidative membrane damage directly impairs fertilisation by disrupting zona pellucida binding and sperm penetration. Clinical studies have associated Vitamin E supplementation with improved endometrial thickness and blood flow — critical determinants of successful embryo implantation — and with improved oocyte maturation rates and fertilisation outcomes in IVF cycles. Vitamin E works synergistically with Selenium in Glasterone-D Plus — Vitamin E neutralises lipid-phase free radicals while Selenium-dependent enzymes address aqueous-phase reactive oxygen species — together providing comprehensive two-pathway antioxidant protection of the follicular environment.
Calcium 220mg — Oocyte Activation and Reproductive Cellular Signalling:
Calcium plays indispensable roles in female reproductive biology beyond its structural contribution to bone health. At the moment of fertilisation, the penetrating sperm triggers a series of calcium oscillations — precisely timed waves of calcium release from intracellular stores — throughout the oocyte cytoplasm that initiate oocyte activation, trigger completion of meiosis II, and set the stage for the first mitotic divisions of the developing embryo. Without adequate intracellular calcium availability and signalling capacity, this activation cascade fails or is incomplete — resulting in fertilisation failure or early embryo arrest even when morphologically normal eggs and sperm are present. Adequate calcium nutrition ensures the oocyte maintains its calcium stores and signalling machinery throughout maturation. Calcium also regulates granulosa cell function and steroidogenesis, supports smooth muscle contractility in the fallopian tubes to facilitate embryo transport, and contributes to overall hormonal signalling integrity throughout the reproductive system. The 220mg calcium in Glasterone-D Plus contributes meaningfully to daily calcium requirements — particularly important for women whose dietary calcium intake from dairy and other sources may be insufficient.
Dosage and Administration
⚠️ Always take exactly as advised by your gynaecologist or reproductive specialist. For IVF preparation, begin supplementation at least 3 months before the planned stimulation cycle. Never exceed the recommended dose.
| Supplement | Recommended Dose | Frequency | When to Take |
|---|---|---|---|
| Glasterone-D Plus | 1 tablet | Once daily | With a main meal |
Usage Guidelines:
- Take 1 tablet once daily with a main meal — food significantly improves absorption of fat-soluble vitamins D3 and E and reduces any mild gastrointestinal discomfort from the mineral components
- For IVF preparation — begin supplementation at least 3 months before the planned ovarian stimulation cycle; oocyte development (folliculogenesis) takes approximately 3 months and nutritional support must be sustained throughout this period to benefit the cohort of follicles being recruited for stimulation
- For diminished ovarian reserve — consistent daily supplementation for a minimum of 3 to 6 months is recommended before reassessing AMH, AFC, and FSH levels; ovarian reserve markers change slowly and require sustained nutritional support
- Continue supplementation throughout the IVF stimulation and retrieval cycle as advised by your reproductive specialist — the antioxidant protection of developing follicles is most critical during the active stimulation phase
- Do not take additional high-dose Selenium supplements concurrently — the 200mcg Selenium in Glasterone-D Plus is at the upper recommended daily intake; exceeding 400mcg daily from all sources risks selenium toxicity
- Combine Glasterone-D Plus with a balanced Mediterranean-style diet rich in antioxidants, healthy fats, and lean protein — optimal nutrition amplifies the supplement's reproductive health benefits
- Maintain regular moderate physical activity and a healthy body weight — both significantly influence ovarian reserve, hormonal balance, and IVF outcomes independently of supplementation
Active Ingredients Per Tablet
| Ingredient | Amount per Tablet | Primary Reproductive Role |
|---|---|---|
| Diosgenin | 20mg | Phytoestrogenic follicular support — FSH modulation — anti-inflammatory |
| Selenium | 200mcg | Oocyte antioxidant protection — GPx enzyme cofactor — thyroid support |
| Vitamin D3 (Cholecalciferol) | 25mcg (1000 IU) | AMH regulation — FSH receptor expression — endometrial receptivity |
| Vitamin E (alpha-tocopherol) | 180mg | Follicular fluid antioxidant — oocyte membrane protection — endometrial blood flow |
| Calcium | 220mg | Oocyte activation — cellular signalling — bone health |
How Glasterone-D Plus Differs from Ovatex-D:
| Feature | Glasterone-D Plus | Ovatex-D |
|---|---|---|
| Manufacturer | Galaxy Nutraceuticals | Geneva Pharmaceuticals |
| Diosgenin dose | 20mg | 25mg |
| Primary positioning | Diminished ovarian reserve and IVF support | General female fertility and egg quality |
| Selenium | 200mcg | 200mcg |
| Vitamin D3 | 25mcg (1000 IU) | 25mcg (1000 IU) |
| Vitamin E | 180mg | 180mg |
| Calcium | 220mg | 220mg |
Both supplements share the same core ingredient profile — Glasterone-D Plus is specifically positioned for the more clinically challenging scenarios of diminished ovarian reserve and IVF preparation.
Who Should NOT Take Glasterone-D Plus?
Do not take if you:
- Are allergic to any ingredient in the tablet — particularly those with known sensitivity to wild yam or steroidal saponins
- Have hypercalcaemia (elevated blood calcium) — additional calcium supplementation may worsen this condition
- Have selenium toxicity or are taking other high-dose Selenium supplements — 200mcg is at the upper safe daily intake limit; never combine with additional Selenium products
- Have sarcoidosis, hyperparathyroidism, or other conditions causing hypersensitivity to Vitamin D — Vitamin D3 supplementation risks dangerous hypercalcaemia
- Have hormone-sensitive conditions including oestrogen receptor-positive breast cancer, uterine fibroids, or endometriosis — Diosgenin's phytoestrogenic properties require specialist assessment before use in hormone-sensitive conditions
Always consult your reproductive specialist before taking Glasterone-D Plus if you:
- Are currently undergoing IVF or assisted reproductive treatment — always inform your reproductive endocrinologist and embryologist of all supplements being taken as they may adjust stimulation protocols accordingly
- Are pregnant — confirm appropriateness of all ingredient doses during pregnancy with your obstetrician
- Have kidney disease (گردے کی بیماری) — calcium and Vitamin D metabolism is impaired in kidney disease with significant risk of hypercalcaemia
- Have a history of kidney stones — calcium supplementation may increase stone risk in susceptible individuals; Vitamin D3 also increases calcium absorption
- Have thyroid disease (تھائیرائیڈ کی بیماری) — Selenium affects thyroid hormone metabolism; monitor thyroid function
- Are taking calcium channel blockers, thiazide diuretics, or Digoxin — calcium and Vitamin D interactions with these medicines require medical monitoring
- Are taking Warfarin or anticoagulants — high-dose Vitamin E can enhance anticoagulant effect; monitor INR
- Are taking other Vitamin D supplements — assess total daily Vitamin D3 intake from all sources to avoid excessive accumulation
Side Effects
Common and Generally Mild:
- Mild nausea or stomach discomfort — most common; significantly reduced by taking with food
- Mild constipation — calcium supplementation related; increase fluid and dietary fibre intake
- Mild bloating — mineral supplement related; usually temporary and self-limiting
- Headache — mild and usually temporary in the first week of supplementation
Monitor and Report to Your Doctor:
- Symptoms of hypercalcaemia — nausea, excessive thirst, frequent urination, confusion, muscle weakness — from excess Vitamin D3 and calcium combined with dietary sources; seek immediate medical evaluation
- Symptoms of selenium excess with prolonged use above recommended amounts — brittle nails, hair loss, garlic breath odour, fatigue — do not combine with other Selenium supplements
- Unusual hormonal symptoms — breast tenderness, spotting, or unexpected hormonal changes — from Diosgenin phytoestrogenic activity; report to your gynaecologist
- Signs of Vitamin D toxicity with excessive supplementation from multiple sources — weakness, confusion, loss of appetite — always assess total daily Vitamin D from all products
Drug Interactions
| Medicine / Substance | Possible Interaction |
|---|---|
| Thiazide diuretics (e.g., Hydrochlorothiazide) | Reduce renal calcium excretion — combined with Glasterone-D Plus calcium and Vitamin D3, hypercalcaemia risk increases; monitor blood calcium |
| Calcium channel blockers (e.g., Amlodipine, Verapamil) | Calcium supplementation may theoretically reduce calcium channel blocker effectiveness — monitor blood pressure during combined use |
| Digoxin | Hypercalcaemia from excess Vitamin D3 and calcium increases Digoxin toxicity risk — monitor Digoxin levels and cardiac status |
| Warfarin / anticoagulants | High-dose Vitamin E enhances anticoagulant effect — monitor INR closely during supplementation; inform your haematologist |
| Vitamin D supplements (other sources) | Assess total daily Vitamin D3 intake from all supplements and fortified foods — excessive combined intake risks hypervitaminosis D and hypercalcaemia |
| Iron supplements | Calcium reduces iron absorption — take iron supplements and Glasterone-D Plus at least 2 hours apart |
| Levothyroxine (thyroid medicine) | Calcium reduces Levothyroxine absorption — take at least 4 hours apart; Selenium also affects thyroid function; monitor thyroid status |
| Bisphosphonates (e.g., Alendronate for osteoporosis) | Calcium significantly reduces bisphosphonate absorption — take at least 2 hours apart |
| Gonadotrophin stimulation medicines (IVF) | Always inform your reproductive specialist — antioxidant supplements may influence follicular response to stimulation; specialist guidance on continuing or pausing supplementation during active stimulation is essential |
| Alcohol (شراب) | Impairs Vitamin D activation, increases oxidative stress, and directly counteracts the antioxidant reproductive benefits of Glasterone-D Plus — avoid during supplementation |
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from moisture and direct sunlight
- Keep in original blister pack until use
- Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
- Do not use after the expiry date printed on the pack
Frequently Asked Questions (FAQs)
Q: How long should I take Glasterone-D Plus before my IVF cycle?
Begin supplementation at least 3 months before your planned IVF stimulation cycle — folliculogenesis takes approximately 3 months and the nutritional support of Glasterone-D Plus must be sustained throughout this entire period to benefit the cohort of follicles being recruited for your stimulation cycle; starting supplementation just weeks before stimulation provides insufficient time for meaningful oocyte quality improvement.
Q: Can Glasterone-D Plus improve my AMH levels?
Vitamin D3 in Glasterone-D Plus directly supports AMH production by ovarian granulosa cells — clinical studies demonstrate that correcting Vitamin D deficiency produces measurable improvements in AMH levels; however AMH reflects the total remaining follicular pool and supplementation supports rather than regenerates follicles; improvements are most meaningful in women whose low AMH is partly driven by nutritional deficiencies rather than absolute follicular exhaustion.
Q: Is Glasterone-D Plus safe to continue during an active IVF stimulation cycle?
Always inform your reproductive specialist and embryologist that you are taking Glasterone-D Plus before starting stimulation — most reproductive specialists support continuing antioxidant supplementation during stimulation as follicular oxidative protection is most critical during this phase; however your specialist may have specific protocol preferences and their guidance takes absolute precedence.
Q: Can I take Glasterone-D Plus alongside other fertility supplements?
Always disclose all supplements to your reproductive specialist — particular care is needed regarding total daily Selenium intake (never exceed 400mcg from all sources), total Vitamin D3 from all products (excessive combined intake risks hypercalcaemia), and total Vitamin E (high combined doses enhance anticoagulant effects); your specialist will advise on the safest and most effective supplement combination for your individual clinical situation.
Medical Disclaimer: Glasterone-D Plus is a dietary supplement — not a pharmaceutical medicine. It is not intended to diagnose, treat, cure, or prevent any disease including infertility or diminished ovarian reserve. These statements describe the nutritional roles of ingredients based on scientific literature and have not been evaluated as pharmaceutical drug claims. Always consult your gynaecologist or reproductive specialist before starting supplementation, particularly if you are undergoing IVF or have been diagnosed with diminished ovarian reserve.
